Supernus Pharmaceuticals (SUPN) Treasury Shares (2020 - 2026)
Supernus Pharmaceuticals (SUPN) reported Treasury Shares of $355477.0 for Q1 2026, up 79.79% year-over-year from $197720.0 in Q1 2025, and down 10.39% quarter-over-quarter from $396693.0 in Q4 2025.
Supernus Pharmaceuticals (SUPN) Treasury Shares (2020 - 2026) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 7 years of Treasury Shares data on file, last reported at $355477.0 in Q1 2026.
- Treasury Shares for Q1 2026 came in at $355477.0, up 79.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $355477.0 (up 79.79% YoY), and the FY2025 annual result was $396693.0, up 4.9% from the prior year.
- Treasury Shares retreated to $355477.0 in Q1 2026 per SUPN's latest filing, from $396693.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $419216.0 in Q2 2025 and troughed at $131210.0 in Q1 2022.
- A 5-year average of $302868.9 and a median of $338730.0 in 2023 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares surged 311.92% in 2022, then slumped 50.18% in 2025.
- A 5-year view of Treasury Shares shows it stood at $131960.0 in 2022, then surged by 105.84% to $271630.0 in 2023, then soared by 39.22% to $378165.0 in 2024, then increased by 4.9% to $396693.0 in 2025, then dropped by 10.39% to $355477.0 in 2026.
- Business Quant data shows SUPN's Treasury Shares at $355477.0 in Q1 2026, $396693.0 in Q4 2025, and $397543.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 107.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 4.80 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 1.42 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 17.13 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 19.58 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 7.24 Mn |
| 10 | Supernus Pharmaceuticals | 2.63 Bn | 2.24 Bn | - | 355,477.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 355,477.00 |
| Mar 31, 2026 | 355,477.00 |
| Dec 31, 2025 | 396,693.00 |
| Dec 31, 2025 | 396,693.00 |
| Sep 30, 2025 | 397,543.00 |
| Sep 30, 2025 | 397,543.00 |
| Jun 30, 2025 | 419,216.00 |
| Jun 30, 2025 | 419,216.00 |
| Mar 31, 2025 | 197,720.00 |
| Mar 31, 2025 | 197,720.00 |
| Dec 31, 2024 | 378,165.00 |
| Dec 31, 2024 | 378,165.00 |
| Sep 30, 2024 | 383,300.00 |
| Sep 30, 2024 | 383,300.00 |
| Jun 30, 2024 | 407,200.00 |
| Jun 30, 2024 | 407,200.00 |
| Mar 31, 2024 | 396,908.00 |
| Mar 31, 2024 | 396,908.00 |
| Dec 31, 2023 | 271,630.00 |
| Dec 31, 2023 | 271,630.00 |